# Metformin and Prevention of Cardiovascular Events in Patients With Acute Myocardial Infarction and Prediabetes (MIMET)

> **NCT05182970** · PHASE3 · RECRUITING · sponsor: **Karolinska Institutet** · enrollment: 5160 (estimated)

## Conditions studied

- PreDiabetes
- Acute Myocardial Infarction
- Non ST Elevation Myocardial Infarction
- ST Elevation Myocardial Infarction

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT05182970
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-02
- **Primary completion:** 2026-05
- **Final completion:** 2026-05
- **Target enrollment:** 5160 (ESTIMATED)
- **Last updated:** 2024-04-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05182970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05182970, "Metformin and Prevention of Cardiovascular Events in Patients With Acute Myocardial Infarction and Prediabetes (MIMET)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05182970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*